Sentient Science and the CMI faculty were recently awarded
funding from the U.S. Navy Small Business Technology Transfer
(STTR) for their proposed Bioelectronic Fusion Sensor
To address the Navy’s need for a common, scalable,
platform for multi-modal 1pA level current sensing for
Electrocardiogram (ECG), Electroencephalogram (EEG), and
Electrodermal Response (EDR) to be fielded as a miniature wearable
device with non-contact electrodes, Sentient and UB propose to
develop the Bioelectronic Fusion Sensor System (BioFuSenS.
BioFuSenS will be a modular, real-time, low cost, low bandwidth,
open standards-based system that, includes autonomous prediction,
health monitoring and management.
In Phase I, the team will demonstrate feasibility through
transistor-level IC simulations, thorough nonlinear systems
analysis, and data-model fusion and noise handling simulations for
ECG sensing. In Phase II, they will develop and validate a
prototype, demonstrate multi-modal, model-based detection with
noise filtering, and optimize the design to meet size, weight,
power, and cost (SWAP-C) requirements.
In Sentient CEOWard Thomas’s words: “This is such
great news. The sensor in the cap commercial plan is a winner. Our
first medical sensor funding. Our first team win with The
University at Buffalo! I'm sure the first of many.”